BCG’s Vikram Aggarwal on why medtech leaders are shifting from cost-cutting to growth, productivity, and scaling GenAI in 2025.
Vikram Aggarwal
Managing Director & PartnerGlobal Sector Leader, Medical Devices and Technology New York
Education
- PhD, biomedical engineering, The Johns Hopkins University
- MSE, biomedical engineering, The Johns Hopkins University
- BASc, honours computer engineering, University of Waterloo
Honors and Awards
- Siebel Scholar, 2011
Vikram Aggarwal is the global leader for Boston Consulting Group’s medical devices and technology work, and a core member of the firm’s Health Care, and Marketing, Sales & Pricing practices.
Vikram focuses on growth strategy, commercial model transformation, and go-to-market strategy. He is the global lead for next-generation sales in medtech, and specializes in digitally enabled selling models leveraging advanced analytics for both medtech and biopharma clients. Since joining the firm in 2012, Vikram has worked with clients in a range of industries, including animal health, hearing aids, ophthalmology, and life science tools and diagnostics.
Vikram also leads BCG’s Advanced Degree Candidate (ADC) recruiting efforts in New York for candidates with PhDs, MDs, JDs, and Post Docs. He has previous industry experience in research, software consulting, hardware engineering, and as a medical devices entrepreneur.
